Selective autophagy receptor p62/SQSTM1, a pivotal player in stress and aging

AV Kumar, J Mills, LR Lapierre - Frontiers in cell and developmental …, 2022 - frontiersin.org
Efficient proteostasis is crucial for somatic maintenance, and its decline during aging leads
to cellular dysfunction and disease. Selective autophagy is a form of autophagy mediated by …

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration

H Querfurth, HK Lee - Molecular neurodegeneration, 2021 - Springer
Novel targets to arrest neurodegeneration in several dementing conditions involving
misfolded protein accumulations may be found in the diverse signaling pathways of the …

The lysosome as a cellular centre for signalling, metabolism and quality control

RE Lawrence, R Zoncu - Nature cell biology, 2019 - nature.com
Long known as terminal degradation stations, lysosomes have emerged as sophisticated
signalling centres that govern cell growth, division and differentiation. Lysosomes interface …

Targeting the biology of aging with mTOR inhibitors

JB Mannick, DW Lamming - Nature Aging, 2023 - nature.com
Inhibition of the protein kinase mechanistic target of rapamycin (mTOR) with the Food and
Drug Administration (FDA)-approved therapeutic rapamycin promotes health and longevity …

Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities

FM Menzies, A Fleming, A Caricasole, CF Bento… - Neuron, 2017 - cell.com
Autophagy is a conserved pathway that delivers cytoplasmic contents to the lysosome for
degradation. Here we consider its roles in neuronal health and disease. We review …

Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles

L Galluzzi, JM Bravo-San Pedro, B Levine… - Nature reviews Drug …, 2017 - nature.com
Autophagy is central to the maintenance of organismal homeostasis in both physiological
and pathological situations. Accordingly, alterations in autophagy have been linked to …

Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis

J Mandrioli, R D'Amico, E Zucchi, S De Biasi… - Nature …, 2023 - nature.com
In preclinical studies rapamycin was found to target neuroinflammation, by expanding
regulatory T cells, and affecting autophagy, two pillars of amyotrophic lateral sclerosis (ALS) …

Effect of rapamycin on aging and age-related diseases—past and future

R Selvarani, S Mohammed, A Richardson - Geroscience, 2021 - Springer
In 2009, rapamycin was reported to increase the lifespan of mice when implemented later in
life. This observation resulted in a sea-change in how researchers viewed aging. This was …

[HTML][HTML] Metabolic control of longevity

C López-Otín, L Galluzzi, JMP Freije, F Madeo… - Cell, 2016 - cell.com
Several metabolic alterations accumulate over time along with a reduction in biological
fitness, suggesting the existence of a" metabolic clock" that controls aging. Multiple inborn …

Autophagy induction as a therapeutic strategy for neurodegenerative diseases

A Djajadikerta, S Keshri, M Pavel, R Prestil… - Journal of molecular …, 2020 - Elsevier
Autophagy is a major, conserved cellular pathway by which cells deliver cytoplasmic
contents to lysosomes for degradation. Genetic studies have revealed extensive links …